PATENT CLAIM ANALYSIS

Application Number: 15945408
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-08
Patent Classification: ["514", "570000"]

Abstract:
The present invention relates to compounds of: or a pharmaceutically acceptable salt thereof, wherein A is C 5  alkyl, C 6  alkyl, C 5  alkenyl, C 6  alkenyl, C(O)—(CH 2 ) n —CH 3  or CH(OH)—(CH 2 ) n —CH 3  wherein n is 3 or 4; R 1  is H, F or OH; R 2  is C 5  alkyl, C 6  alkyl, C 5  alkenyl, C 6  alkenyl, C(O)—(CH 2 ) n —CH 3  or CH(OH)—(CH 2 ) n —CH 3  wherein n is 3 or 4; R 3  is H, F, OH or CH 2 Ph; R 4  is H, For OH; Q is      1) (CH 2 ) m C(O)OH wherein m is 1 or 2, 2) CH(CH 3 )C(O)OH, 3) C(CH 3 ) 2 C(O)OH, 4) CH(F)—C(O)OH, 5) CF 2 —C(O)OH, or 6) C(O)—C(O)OH; and compositions comprising the same and the method using the same for the prevention or treatment of various fibrotic diseases and conditions in subjects, including pulmonary fibrosis, liver fibrosis, skin fibrosis, renal fibrosis, pancreas fibrosis, systemic sclerosis, cardiac fibrosis or macular degeneration.

Claim (Index 3):
The compound of  claim 2 , wherein the pharmaceutically acceptable salt of said compound is sodium.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 91.0
- Lexical Diversity: 3.78378
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15852977', '15526405', '15515048', '13882363', '14347018']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7899511365416472
- 35 USC 102 Novelty (BERT): 0.5403039247594106
- Combined Prediction Score: 0.7649864153634236
- Mean Citation Score: 295.821512
- Max Citation Score: 379.6809
- Similarity Product: 358.27542863262886

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test